Bordetella pertussis

  1. Bordetella pertussis
  2. Pertussis: Common Questions and Answers
  3. Pertussis: Common Questions and Answers
  4. Bordetella pertussis
  5. Pertussis: Common Questions and Answers
  6. Bordetella pertussis


Download: Bordetella pertussis
Size: 25.59 MB

Bordetella pertussis

(Bergey et al. 1923) Moreno-López 1952 Bordetella pertussis is a B. pertussis is The bacterium is spread by airborne droplets; its incubation period is 7–10 days on average (range 6–20 days). B. pertussis. B. pertussis B. bronchiseptica, the genome size is greatly reduced. This is mainly due to the adaptation to one host species (human) and the loss of capability of survival outside of a host body. History [ ] The disease pertussis was first described by French physician Taxonomy [ ] The genus B. pertussis B. parapertussis, B. bronchiseptica, B. avium, B. hinzii, B. holmesii, B. trematum, B. ansorpii and B. petrii. B. pertussis, B. parapertussis causes a disease similar to whooping cough in humans, and B. bronchiseptica infects a range of mammal hosts, including humans, and causes a spectrum of respiratory disorders. Pertussis [ ] Main article: Pertussis is an infection of the [ citation needed] B. pertussis infects its host by colonizing lung epithelial cells. The bacterium contains a surface protein, B. pertussis has the ability to inhibit the function of the host's immune system. The toxin, known as Another toxin that inhibits the immune response is the The infection occurs mostly in children under the age of one when they are B. pertussis inhibits the immune response, so very little mucus is generated in the lungs. A prolonged cough may be irritating and sometimes a disabling cough may go undiagnosed in adults for many months. Prevention [ ] As a zoonotic disease [ ] U...

Pertussis: Common Questions and Answers

Pertussis, also known as whooping cough, remains a public health concern despite expanded immunization recommendations over the past three decades. The presentation of pertussis, which is variable and evolves over the course of the disease, includes nonspecific symptoms in the catarrhal stage, coughing with the classic whooping in the paroxysmal stage, and persistent cough in the convalescent stage. When there is clinical suspicion for pertussis, the diagnosis should be confirmed using polymerase chain reaction testing, which has replaced culture as the preferred confirmatory test. Recent evidence has confirmed a waning of acquired immunity following pertussis immunization or infection, leading to changes in tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) immunization recommendations. Patients 11 years or older should receive at least one dose of Tdap, although Tdap may replace any dose of the tetanus and diphtheria toxoids (Td) vaccine. All pregnant patients should receive Tdap between 27 and 36 weeks' gestation with each pregnancy to convey immunity to the newborn. Cocooning (vaccinating close contacts of high-risk individuals) is no longer recommended because immunized patients can still contract and transmit pertussis. A history of seizure or hypotonic-hyporesponsive episodes after a prior pertussis vaccination is no longer a contraindication to immunization. Antibiotic treatment is intended to prevent transmission of pertussis to others and d...

Pertussis: Common Questions and Answers

Pertussis, also known as whooping cough, remains a public health concern despite expanded immunization recommendations over the past three decades. The presentation of pertussis, which is variable and evolves over the course of the disease, includes nonspecific symptoms in the catarrhal stage, coughing with the classic whooping in the paroxysmal stage, and persistent cough in the convalescent stage. When there is clinical suspicion for pertussis, the diagnosis should be confirmed using polymerase chain reaction testing, which has replaced culture as the preferred confirmatory test. Recent evidence has confirmed a waning of acquired immunity following pertussis immunization or infection, leading to changes in tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) immunization recommendations. Patients 11 years or older should receive at least one dose of Tdap, although Tdap may replace any dose of the tetanus and diphtheria toxoids (Td) vaccine. All pregnant patients should receive Tdap between 27 and 36 weeks' gestation with each pregnancy to convey immunity to the newborn. Cocooning (vaccinating close contacts of high-risk individuals) is no longer recommended because immunized patients can still contract and transmit pertussis. A history of seizure or hypotonic-hyporesponsive episodes after a prior pertussis vaccination is no longer a contraindication to immunization. Antibiotic treatment is intended to prevent transmission of pertussis to others and d...

Bordetella pertussis

(Bergey et al. 1923) Moreno-López 1952 Bordetella pertussis is a B. pertussis is The bacterium is spread by airborne droplets; its incubation period is 7–10 days on average (range 6–20 days). B. pertussis. B. pertussis B. bronchiseptica, the genome size is greatly reduced. This is mainly due to the adaptation to one host species (human) and the loss of capability of survival outside of a host body. History [ ] The disease pertussis was first described by French physician Taxonomy [ ] The genus B. pertussis B. parapertussis, B. bronchiseptica, B. avium, B. hinzii, B. holmesii, B. trematum, B. ansorpii and B. petrii. B. pertussis, B. parapertussis causes a disease similar to whooping cough in humans, and B. bronchiseptica infects a range of mammal hosts, including humans, and causes a spectrum of respiratory disorders. Pertussis [ ] Main article: Pertussis is an infection of the [ citation needed] B. pertussis infects its host by colonizing lung epithelial cells. The bacterium contains a surface protein, B. pertussis has the ability to inhibit the function of the host's immune system. The toxin, known as Another toxin that inhibits the immune response is the The infection occurs mostly in children under the age of one when they are B. pertussis inhibits the immune response, so very little mucus is generated in the lungs. A prolonged cough may be irritating and sometimes a disabling cough may go undiagnosed in adults for many months. Prevention [ ] As a zoonotic disease [ ] U...

Pertussis: Common Questions and Answers

Pertussis, also known as whooping cough, remains a public health concern despite expanded immunization recommendations over the past three decades. The presentation of pertussis, which is variable and evolves over the course of the disease, includes nonspecific symptoms in the catarrhal stage, coughing with the classic whooping in the paroxysmal stage, and persistent cough in the convalescent stage. When there is clinical suspicion for pertussis, the diagnosis should be confirmed using polymerase chain reaction testing, which has replaced culture as the preferred confirmatory test. Recent evidence has confirmed a waning of acquired immunity following pertussis immunization or infection, leading to changes in tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) immunization recommendations. Patients 11 years or older should receive at least one dose of Tdap, although Tdap may replace any dose of the tetanus and diphtheria toxoids (Td) vaccine. All pregnant patients should receive Tdap between 27 and 36 weeks' gestation with each pregnancy to convey immunity to the newborn. Cocooning (vaccinating close contacts of high-risk individuals) is no longer recommended because immunized patients can still contract and transmit pertussis. A history of seizure or hypotonic-hyporesponsive episodes after a prior pertussis vaccination is no longer a contraindication to immunization. Antibiotic treatment is intended to prevent transmission of pertussis to others and d...

Bordetella pertussis

(Bergey et al. 1923) Moreno-López 1952 Bordetella pertussis is a B. pertussis is The bacterium is spread by airborne droplets; its incubation period is 7–10 days on average (range 6–20 days). B. pertussis. B. pertussis B. bronchiseptica, the genome size is greatly reduced. This is mainly due to the adaptation to one host species (human) and the loss of capability of survival outside of a host body. History [ ] The disease pertussis was first described by French physician Taxonomy [ ] The genus B. pertussis B. parapertussis, B. bronchiseptica, B. avium, B. hinzii, B. holmesii, B. trematum, B. ansorpii and B. petrii. B. pertussis, B. parapertussis causes a disease similar to whooping cough in humans, and B. bronchiseptica infects a range of mammal hosts, including humans, and causes a spectrum of respiratory disorders. Pertussis [ ] Main article: Pertussis is an infection of the [ citation needed] B. pertussis infects its host by colonizing lung epithelial cells. The bacterium contains a surface protein, B. pertussis has the ability to inhibit the function of the host's immune system. The toxin, known as Another toxin that inhibits the immune response is the The infection occurs mostly in children under the age of one when they are B. pertussis inhibits the immune response, so very little mucus is generated in the lungs. A prolonged cough may be irritating and sometimes a disabling cough may go undiagnosed in adults for many months. Prevention [ ] As a zoonotic disease [ ] U...